Diwakar Davar
Clinical trials sponsored by Diwakar Davar, explained in plain language.
-
New hope for hard-to-treat melanoma: drug combo shows promise in early trial
Disease control OngoingThis study tests whether a combination of two immunotherapy drugs (zimberelimab and domvanalimab) can shrink tumors in people with advanced melanoma that has stopped responding to standard PD-1 inhibitors. The trial enrolled 8 adults with cutaneous melanoma or unknown primary mel…
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated May 26, 2026 06:56 UTC
-
Poop pills plus immunotherapy: a new hope for melanoma that never came
Disease control TerminatedThis study aimed to see if adding a healthy donor fecal transplant (hdFMT) to standard immunotherapy (pembrolizumab/lenvatinib) could help people with advanced melanoma that stopped responding to treatment. The plan was to enroll about 0 participants and follow them for 104 weeks…
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated May 26, 2026 06:54 UTC
-
New drug combo shows promise in shrinking advanced melanoma before surgery
Disease control OngoingThis study tests whether a combination of two immunotherapy drugs (dostarlimab and cobolimab) works better than one drug alone (dostarlimab) in shrinking advanced melanoma before surgery. About 48 adults with stage III or limited stage IV melanoma that can be removed will receive…
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated May 26, 2026 06:52 UTC